|
[1]
|
National Health Commission of the Peoples’s Republic of China. Notification of the switch on poliomyelitis vaccine immunization strategy of national immunization programme, in China. 2016-4-29. http://www.nhc.gov.cn/jkj/s3582/201604/5b23c513cfcb4fe7848d52a98f02b1ea.shtml. (In Chinese). http://www.nhc.gov.cn/jkj/s3582/201604/5b23c513cfcb4fe7848d52a98f02b1ea.shtml |
|
[2]
|
WHO. Standard operating procedures: Responding to a poliovirus event or outbreak version 3. Geneva (Switzerland): World Health Organization; 2019 Jan. License: CC BY-NC-SA 3.0 IGO. |
|
[3]
|
Ning J, Yang H, Adili S, Cao L, Wang PS, Fan CX, et al. Emergency response to a type Ⅱ vaccine-derived poliovirus first detected in sewage after the polio immunization strategy switch in China. Chin J Vaccin Immun 2019;25(4):373-7, 387. http://lib.cqvip.com/Qikan/Article/Detail?id=7100100761&from=Qikan_Search_Index. (In Chinese). http://lib.cqvip.com/Qikan/Article/Detail?id=7100100761&from=Qikan_Search_Index |
|
[4]
|
Q&A With Michel Zaffran: cVDPV2 and The Vaccine Available to Stop it. http://polioeradication.org/news-post/caught-between-a-rock-and-a-hard-place-cvdpv2-and-the-vaccine-available-to-stop-it/.http://polioeradication.org/news-post/caught-between-a-rock-and-a-hard-place-cvdpv2-and-the-vaccine-available-to-stop-it/ |
|
[5]
|
Wen N, Fan CX, Yan DM, Zhu SL, Wang HB, Liu B, et al. The epidemiology characteristics analysis of vaccine-derived poliovirus and cases in China, 2001–2013. Chin J Vaccin Immun 2014;20(3):210-5. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgjhmy201403004. (In Chinese). http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgjhmy201403004 |
|
[6]
|
McCarthy KA, Chabot-Couture G, Famulare M, Lyons HM, Mercer LD. The risk of type 2 oral polio vaccine use in post-cessation outbreak response. BMC Med 2017;15(1):175. http://dx.doi.org/10.1186/s12916-017-0937-yCrossRef
|